A Phase I Trial To Evaluate Repetitive Intravenous Doses Of Gadolinium-Texaphyrin As A Radiosensitizer In Patients With Glioblastoma Multi Forme
Phase of Trial: Phase I
Latest Information Update: 31 Oct 2007
At a glance
- Drugs Motexafin gadolinium (Primary)
- Indications Astrocytoma; Glioblastoma
- Focus Adverse reactions; Pharmacokinetics
- 31 Oct 2007 Status change from suspended to completed.
- 24 Sep 2005 New trial record.